Treatment with CTLA4-Ig inhibits rejection of liver allografts from Flt3-ligand-treated donors

By Fu F.   Li W.   Lu L.   Fung J.J.   Thomson A.W.   Qian S.  

Transplantation Proceedings, Vol. 31, Iss. 1, 1999-02 ,pp. : 453-453

Elsevier

Access to resources Recommend Favorite

Prevention of T-cell activation by rhCTLA4-Ig and anti-CD40L monoclonal antibody results in indefinite islet allograft survival

By Rastellini C.   Salam A.   Kuddus R.   Aitouche A.   Subbotin V.   Braun M.   Leach R.   Peach R.   Fung J.J.   Starzl T.E.   Rao A.S.  

Transplantation Proceedings, Vol. 31, Iss. 1, 1999-02 ,pp. : 1242-1243

Elsevier

Access to resources Recommend Favorite

Inhibition of human anti-pig T cell response by anti-CD2, anti-CD40L, and CTLA4-Ig: a comparative study

By Xu Y.   Ryan D.   Wu C.   Bazin H.   Latinne D.   White-Scharf M.E.   Thall A.D.  

Transplantation Proceedings, Vol. 32, Iss. 5, 2000-08 ,pp. : 926-926

Elsevier

Access to resources Recommend Favorite

Synergism of CTLA4-IG and Anti-CD4 Monoclonal Antibody Treatment in a Rat Kidney Transplant Model

By Graser E.   Risch K.   Linsley P.S.   Hancock W.W.   Muller A.   Brock J.   Reinke P.   Kupiec-Weglinski J.W.   Volk H.D.   Lehmann M.  

Transplantation Proceedings, Vol. 29, Iss. 1, 1997-02 ,pp. : 1307-1309

Elsevier

Access to resources Recommend Favorite

Efficacy of FK506, leflunomide, anti-CD4, and CTLA4IG treatments in rat to mouse pancreas xenograft transplantation

By Yin D.P.   Sankary H.N.   Shen J.   Ma L.L.   Blinder L.   Foster P.   Williams J.W.   Chong A.  

Transplantation Proceedings, Vol. 32, Iss. 5, 2000-08 ,pp. : 1003-1004

Elsevier

Access to resources Recommend Favorite